Sudden increase in floaters, light flashes, or curtain-like vision loss may signal an eye emergency requiring prompt retinal ...

A school project prompted 17-year-old Edward Kang to develop an AI tool that may lead to earlier diagnoses of the disorders.

The 4TAZPower study will follow participants with Barth syndrome for 72 weeks to assess the efficacy and safety.

Chief Medical Officer Hendrik Scholl said the company is advancing its lead compound, Tinlarebant, as a potential treatment ...

Older men whose testosterone levels drop or are medically suppressed face a measurably higher risk of age-related macular ...

Life Balance Clinic launches a 10-day Vision Balance Program using integrative therapies to support visual function, ...

Even after its sharp pullback, Space Exploration Technologies' ( SPCX +0.13%) market cap still hovers around $2 trillion.

Scientists have found out how a person develops acute central vision before birth. It turned out that the interaction of a ...

Opus Genetics, Inc. (Nasdaq: IRD) (the “Company”, “Opus Genetics” or “Opus”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients ...

Fifteen months after disastrous clinical trial results slashed the share price, chairman Jeremy Levin is asking major ...

Patients may not know that these treatments are experimental or about the risks they may pose. The latest in AJC's ...

Drivers have been told that if they do not act correctly, they could face serious consequences ...